Prophylactic drugs and cytokine and leptin levels in children with migraine.
The study objective was to evaluate levels of the cytokines tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 and of leptin, and then to determine the relationship between these levels and clinical responses in children with migraine after prophylactic therapy with one of four drugs. In all, 77 children who needed prophylactic drugs were treated with cyproheptadine, amitriptyline, propranolol, or flunarizine. Serum levels of the cytokines and leptin were measured before and 4 months after the treatment. Results were compared by drug for headache frequency, severity, and duration, the PedMIDAS score, and levels of each cytokine and of leptin. Each of the four drugs not only decreased the frequency and duration but also the severity of headache, and the PedMIDAS score. None of the drugs was found to be superior to others in terms of reduction in cytokine levels (P > 0.05). Both cyproheptadine and flunarizine (but not amitriptyline and propranolol) caused an increase in leptin levels (P < 0.05). These data suggest that cytokine levels are related to clinical responses, and might help in objective evaluation of clinical response in migraine. To our knowledge, the present study is the first trial to compare the effects of prophylactic drugs, cytokine levels, and leptin levels in children with migraine.
Hirfanoglu
Tugba
T
Department of Pediatric Neurology, Gazi University Faculty of Medicine, Ankara, Turkey. tugbahirfanoglu@yahoo.com
Serdaroglu
Ayse
A
Gulbahar
Ozlem
O
Cansu
Ali
A
D000293:Adolescent; D000639:Amitriptyline / Q000494:pharmacology; D002491:Central Nervous System Agents / Q000494:pharmacology; D002648:Child; D003533:Cyproheptadine / Q000494:pharmacology; D016207:Cytokines / Q000097:blood*; D005260:Female; D005444:Flunarizine / Q000494:pharmacology; D006801:Humans; D053583:Interleukin-1beta / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D020738:Leptin / Q000097:blood*; D008297:Male; D008881:Migraine Disorders / Q000097:blood* / Q000188:drug therapy*; D011433:Propranolol / Q000494:pharmacology; D013997:Time Factors; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D002491:Central Nervous System Agents; D016207:Cytokines; D053583:Interleukin-1beta; D015850:Interleukin-6; D020738:Leptin; D014409:Tumor Necrosis Factor-alpha; D000639:Amitriptyline; D003533:Cyproheptadine; D011433:Propranolol; D005444:Flunarizine